Get the skinny on this. Novo Nordisk, the Danish pharmaceutical company that manufactures Ozempic, said that it is “very likely” the cost of the popular diabetes-turned-weight loss drug will ...

Americans are paying more than $900 a month for popular weight-loss drugs Ozempic and Wegovy, but drugmakers want to sell generic versions of the drugs for less than $100. That is according to ...

Ozempic, the semaglutide injection made by pharma company Novo Nordisk, is predicted to have its price cut in negotiations with the U.S. government. The drug, which is designed to help patients ...

Kate Moss’ sister issued a warning to anyone taking Ozempic after the English model was rushed to the hospital. Lottie, 26, admitted she took Ozempic for two weeks “a few months ago.” ...

Kate Moss' sister issued a warning to anyone taking Ozempic after the English model was rushed to the hospital. Lottie, 26, admitted she took Ozempic for two weeks "a few months ago." At the time ...

Initially approved to treat Type 2 diabetes, Ozempic and Mounjaro also can help people with Type 1 diabetes lose weight and control their blood sugar levels, a new study finds. Overweight or obese ...

There’s a lot to think about when you're pregnant or trying to get pregnant. If you take Ozempic, you’ll need to talk with your healthcare provider about the risks this medication could pose ...

In June, Jorgensen agreed to testify over the pricing of Ozempic in the U.S., as well as that of the drugmaker's hugely popular weight loss drug Wegovy. Sanders, who chairs the Senate committee ...

Ozempic, the blockbuster diabetes shot made by Novo Nordisk A/S, is “very likely” to be one of the next drugs targeted for a price cut in bargaining with the US government’s Medicare program ...

The diabetes medicine Ozempic has been a veritable cash cow for Novo Nordisk (NYSE: NVO). The company's revenue, earnings, and stock price have been on a tear in recent years -- and no single drug ...

If you buy through links on this page, we may earn a small commission. Here’s our process. Ozempic is a medication approved for the management of type 2 diabetes. It’s sometimes used off-label ...

Sept 17 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of price negotiations ...